4,701
Views
8
CrossRef citations to date
0
Altmetric
Oncology

Cost-effectiveness analysis of the Oncotype DX Breast Recurrence Score test in node-positive early breast cancer

Pages 591-604 | Received 16 Mar 2022, Accepted 12 Apr 2022, Published online: 08 May 2022

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.